Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 488-501
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.488
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.488
Figure 1 The expression of miR-630 in diabetic kidney disease rats.
A: Differential expression of miR-630, renal weight index, and blood glucose in diabetic kidney disease rats; B: The correlations between the expression of miR-630 and clinical parameters, including body weight, serum albumin, renal weight index, blood urea nitrogen, serum creatinine and proteinuria, were analysed by Pearson correlation analysis and linear regression analysis; C: Pathological changes in renal tissue in rats under a high glucose environment (hematoxylin and eosin, × 400). n = 15. Data are presented as mean ± SD, aP < 0.001, bP < 0.001, cP < 0.001, dP < 0.001. DKD: Diabetic kidney disease.
- Citation: Wu QS, Zheng DN, Ji C, Qian H, Jin J, He Q. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World J Diabetes 2024; 15(3): 488-501
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/488.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.488